ReWalk Robotics - RWLK Stock Forecast, Price & News

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Analyst Ratings Changes

Several research analysts recently commented on RWLK shares. HC Wainwright reduced their price target on ReWalk Robotics from $3.50 to $2.50 and set a "buy" rating for the company in a research report on Wednesday. StockNews.com started coverage on ReWalk Robotics in a research report on Saturday, August 6th. They set a "sell" rating for the company.

ReWalk Robotics Stock Up 2.9 %

RWLK opened at $1.06 on Friday. ReWalk Robotics has a 12-month low of $0.81 and a 12-month high of $2.78. The stock has a market cap of $66.33 million, a price-to-earnings ratio of -4.08 and a beta of 2.55. The business has a 50 day moving average of $0.99 and a 200-day moving average of $1.04.

ReWalk Robotics (NASDAQ:RWLK - Get Rating) last released its quarterly earnings data on Friday, May 13th. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by ($0.02). ReWalk Robotics had a negative net margin of 270.83% and a negative return on equity of 17.19%. The business had revenue of $0.88 million during the quarter, compared to analyst estimates of $2.20 million. During the same period in the previous year, the business earned ($0.08) earnings per share. As a group, analysts expect that ReWalk Robotics will post -0.2 earnings per share for the current year.

Insider Transactions at ReWalk Robotics

In other news, major shareholder Global Fund Lp Lind II bought 236,616 shares of the stock in a transaction dated Thursday, June 2nd. The shares were bought at an average price of $1.00 per share, for a total transaction of $236,616.00. Following the completion of the purchase, the insider now owns 4,092,022 shares in the company, valued at $4,092,022. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last quarter, insiders have bought 284,794 shares of company stock worth $285,080. Company insiders own 0.78% of the company's stock.